Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.00
Bid: 68.00
Ask: 68.80
Change: -1.40 (-2.02%)
Spread: 0.80 (1.176%)
Open: 69.40
High: 69.40
Low: 68.00
Prev. Close: 69.40
GABI Live PriceLast checked at -
GCP Asset Backed Income is an Investment Trust

To generate attractive risk-adjusted returns through growing distributions and modest capital appreciation over the long term by investing in predominantly UK loans.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing

11 Dec 2018 07:00

RNS Number : 0328K
GCP Asset Backed Income Fund Ltd
11 December 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR IN OR INTO CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR THE UNITED STATES OF AMERICA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014

11 December 2018

GCP Asset Backed Income Fund Limited

("GCP Asset Backed" or the "Company")

LEI 213800FBBZCQMP73A815

Result of Placing

On 5 December 2018, GCP Asset Backed, which invests in asset backed loans, announced details of a placing of ordinary shares (the "New Shares") at a price of 104.50 pence per New Share targeting gross proceeds in excess of £10 million (the "Placing").

Further to that announcement, the Company has received applications in respect of 12,440,190 New Shares, raising gross proceeds of £13.0 million for the Company.

The net proceeds of the Placing will be used to take advantage of a pipeline of attractive asset backed finance investment opportunities identified by the Investment Manager.

Application has been made for all of the New Shares to be admitted to the premium listing segment of the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities ("Admission"). It is expected that Admission will take effect, and dealings in the New Shares will commence, at 8.00 a.m. (London time) on 13 December 2018.

Share certificates in respect of the New Shares are expected to be despatched in the week commencing 17 December 2018 or as soon as possible thereafter.

Immediately following Admission, the Company will have 329,722,503 ordinary shares and 51,500,000 C shares in issue and therefore the total voting rights in the Company will be 381,222,503. This figure may be used by shareholders as the denominator for the calculations by which they may determine whether or not they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Gravis Capital Management Limited +44 (0) 20 3405 8500

David Conlon

 

 

Dion Di Miceli

 

 

Cenkos Securities plc

 

 

Tom Scrivens

+44 (0)20 7397 1915

 

Oliver Packard

+44 (0)20 7397 1918

 

Sapna Shah

 

+44 (0)20 7397 1922

 

Notes to Editors

The Company is a closed ended investment company traded on the Main Market of the London Stock Exchange. Its investment objective is to generate attractive risk-adjusted returns primarily through regular, growing distributions and modest capital appreciation over the long term.

The Company seeks to meet its investment objective by making investments in a diversified portfolio of predominantly UK based asset backed loans which have contracted, predictable medium to long term cash flows and/or physical assets.

Important Information

The content of this announcement has been prepared by, and is the sole responsibility of, GCP Asset Backed.

GCP Asset Backed is incorporated in Jersey under the Companies (Jersey) Law 1991, as amended, on 7 September 2015 with registered number 119412. The Company is regulated by the Jersey Financial Services Commission (the "JFSC"). The JFSC is protected by both the Collective Investment Funds (Jersey) Law 1988 and the Financial Services (Jersey) Law 1998, as amended, against liability arising from the discharge of its functions under such laws. The JFSC has not reviewed or approved this announcement.

This announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by, Cenkos Securities plc or the Investment Manager or by any of their affiliates or agents as to or in relation to the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or their advisers and any liability therefore is expressly disclaimed. 

Cenkos Securities plc, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as sole placing agent to the Company and is acting for no-one else in connection with the Placing and the contents of this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Cenkos Securities plc nor for providing advice in connection with the Placing and the contents of this announcement or any other matter referred to herein.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIGGGWUPUPRGRU
Date   Source Headline
20th Apr 20227:00 amRNSNet Asset Value and Investment Update
6th Apr 20227:00 amRNSNotice of Annual General Meeting
24th Mar 20227:00 amRNSAnnual Report & Financial Statements
25th Feb 20227:00 amRNSCo-living Group Loan Update
3rd Feb 20227:00 amRNSCo-living Group Loan Update
31st Jan 20227:00 amRNSInvestor Report at 31 December 2021
27th Jan 20227:00 amRNSDividend Declaration
25th Jan 20227:00 amRNSNet Asset Value and Investment Update
22nd Dec 20219:03 amRNSCo-Living 2021 Year End Update
3rd Nov 20217:00 amRNSDividend Declaration
29th Oct 20217:00 amRNSInvestor Report at 30 September 2021
15th Oct 20217:00 amRNSNet Asset Value and Investment Update
28th Sep 20217:00 amRNSHalf-year Report
16th Sep 20217:00 amRNSCo-living Group Loan Update
13th Sep 20217:00 amRNSCo-living Group Loan Update and Net Asset Value
20th Aug 20217:00 amRNSExtension to term of Revolving Credit Facility
30th Jul 20217:00 amRNSInvestor Report at 30 June 2021
22nd Jul 20217:00 amRNSDividend Declaration
15th Jul 20217:00 amRNSNet Asset Value and Investment Update
17th May 20212:13 pmRNSResults of Annual General Meeting
4th May 20217:00 amRNSInvestor Report at 31 March 2021
29th Apr 20215:42 pmRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSDividend Declaration
20th Apr 20217:00 amRNSNet Asset Value and Investment Update
16th Apr 20217:00 amRNSNotice of Annual General Meeting
31st Mar 20217:00 amRNSTotal Voting Rights
23rd Mar 20217:00 amRNSAnnual Report & Financial Statements
18th Mar 20217:00 amRNSTransaction in Own Shares
15th Mar 20217:00 amRNSTransaction in Own Shares
12th Mar 20217:00 amRNSTransaction in Own Shares
10th Mar 20217:00 amRNSTransaction in Own Shares
8th Mar 20217:00 amRNSCompliance with Market Abuse Regulation
29th Jan 20217:00 amRNSInvestor Report at 31 December 2020
26th Jan 20217:00 amRNSDividend Declaration & Scrip Dividend Suspension
18th Jan 20217:00 amRNSNet Asset Value and Investment Update
4th Dec 20207:00 amRNSInvestment Manager change of control
30th Nov 20207:00 amRNSTotal Voting Rights
26th Nov 20207:00 amRNSSpecial Dividend Declaration
5th Nov 20207:00 amRNSTransaction in Own Shares
2nd Nov 20207:00 amRNSTransaction in Own Shares
2nd Nov 20207:00 amRNSInvestor Report at 30 September 2020
30th Oct 20207:00 amRNSTransaction in Own Shares
29th Oct 20207:00 amRNSTransaction in Own Shares
28th Oct 20207:00 amRNSTransaction in Own Shares
19th Oct 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
19th Oct 20207:00 amRNSTransaction in Own Shares
16th Oct 20207:00 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSNet Asset Value and Investment Update
15th Oct 20207:00 amRNSTransaction in Own Shares
12th Oct 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.